H
Hiroshi Maeda
Researcher at Kumamoto University
Publications - 915
Citations - 67944
Hiroshi Maeda is an academic researcher from Kumamoto University. The author has contributed to research in topics: Neocarzinostatin & Nitric oxide. The author has an hindex of 103, co-authored 893 publications receiving 63370 citations. Previous affiliations of Hiroshi Maeda include Osaka University & Okayama University.
Papers
More filters
Journal ArticleDOI
A bioinspired carbon monoxide delivery system prevents acute kidney injury and the progression to chronic kidney disease
Taisei Nagasaki,Hiroshi Maeda,Kazuaki Taguchi,Hiroki Yanagisawa,Kento Nishida,Kazuki Kobayashi,Naoki Wada,Isamu Noguchi,Ryota Murata,Hiromitu Sakai,Hiroaki Kitagishi,Junji Saruwatari,Hiroshi Watanabe,Masaki Otagiri,Panayiotis D. Megaloikonomos +14 more
TL;DR: In this article , a bio-inspired CO delivery system was proposed to prevent the pathological conditions of both acute kidney injury (AKI) and chronic kidney disease (CKD) via the amelioration of hypoxia inducible tubular cell damage, thereby making it an effective cell therapy for treating the progression to CKD.
Patent
Discriminating method for chronic inflammation and kit therefor
TL;DR: In this article, the presence/absence or degree of chronic inflammation is discriminated by measuring the concentration of hyaluronic acid in the inspection sample of urine, a measuring method to use competitive reaction to hyaleronic acid bonding protein is desired.
Journal ArticleDOI
Silver sheathed superconducting tapes made from the bi-system oxide powders mixed with metal Ag or Cu powders
TL;DR: In this paper, the properties of Ag sheathed tapes of the 2212-phase Bi-system were investigated, where calcined powders were mixed with metal powders of Ag and/or Cu by using an attrition-type mill and further heat-treated in vacuum.
Journal ArticleDOI
The Hsp32/HO-1-targeted drug SMA-ZnPP counteracts the proliferation and viability of neoplastic cells in solid tumors and hematologic neoplasms
Karoline V. Gleixner,Matthias Mayerhofer,A. Vales,Alexander Gruze,Winfried F. Pickl,E. Lackner,Christian Sillaber,Christoph C. Zielinski,Hiroshi Maeda,Peter Valent +9 more
TL;DR: In this article, heat shock protein 32 (Hsp32) is a stress-related survival factor that is overexpressed in various neoplastic cells and has been targeted by specific Hsp32-targeting drugs such as styrene male...